Calamos Advisors LLC Adaptive Biotechnologies Corp Transaction History
Calamos Advisors LLC
- $15.7 Billion
- Q1 2025
A detailed history of Calamos Advisors LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Calamos Advisors LLC holds 140,889 shares of ADPT stock, worth $1.56 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
140,889Holding current value
$1.56 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ADPT
# of Institutions
251Shares Held
151MCall Options Held
44.3KPut Options Held
47.8K-
Viking Global Investors LP30MShares$331 Million0.74% of portfolio
-
Rubric Capital Management LP New York, NY13.1MShares$145 Million2.79% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$129 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$123 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.64MShares$73.4 Million0.01% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.58B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...